IDSA News - August-September 2013 (Plain Text Version)
In this issue:
IDSA Joins Forces with AASLD to Develop Hepatitis C Practice Recommendations
Recognizing the rapid development of hepatitis C medications coupled with increasing numbers of people being identified with hepatitis C virus (HCV) infection, IDSA in July announced a collaboration with the American Association for the Study of Liver Disease (AASLD) to develop clinical recommendations for the management of hepatitis C.
Through this collaboration, the societies will review current treatment recommendations and use evidence-based, consensus guidance to develop updated recommendations for treating and managing patients. Recommendations will be updated regularly and made available online.
Earlier this year, in a move strongly supported by IDSA and others, the Centers for Disease Control and Prevention recommended an age-based screening strategy consisting of a one-time test for HCV for those at highest risk, including everyone born between 1945 and 1965. This recommendation was endorsed by the U.S. Preventive Services Task Force in June. The broader testing recommendations likely will detect a substantial number of people who are unaware they are infected.
Currently available drugs and the next generation of direct-acting antivirals that likely will be available later this year offer the potential to treat and cure most patients with HCV infection. Therefore, up-to-date recommendations for the medical management of these patients and their treatment are critical.
Other IDSA Hepatitis C Resources:
The IDSA-AASLD collaboration is the latest effort by the Society to help ID clinicians keep pace with the rapidly changing field of hepatitis.
Earlier, IDSA launched a free, monthly webinar series, the IDSA Hepatitis C Knowledge Network, to educate members about current recommended practices to effectively identify, treat, and manage patients infected with HCV. Archived versions of the first three webinars, including a recent one by David L. Thomas, MD, FIDSA, chair of IDSA’s Hepatitis Task Force, are available online (you must be logged in to access this link). Podcasts of the webinars are also available on iTunes.
Additional clinical and educational resources on HCV are available at www.idsociety.org/Hepatitis_C, including the HCV Core Curriculum (covering from Pathogenesis to Post-SVR Management) and a Hepatitis C Management Discussion Board.